WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2024)
Top pharmaceutical stocks in 2024 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
NBIX
NEUROCRINE BIOSCIENCES INC
$13.72B$137.92$141.802.81%Buy1515.57%54.49%N/AN/A
KMDA
KAMADA LTD
$322.46M$5.61$11.0096.08%Buy115.57%50.54%N/AN/A
AMPH
AMPHASTAR PHARMACEUTICALS INC
$2.11B$43.91$61.5040.06%Buy214.91%-11.88%N/AN/A
LNTH
LANTHEUS HOLDINGS INC
$4.27B$62.24$100.3361.20%Strong Buy68.58%-17.80%N/AN/A
HCM
HUTCHMED (CHINA) LTD
$2.93B$16.80$19.5516.37%Buy24.07%33.58%N/AN/A
PCRX
PACIRA BIOSCIENCES INC
$1.36B$29.22$48.7566.84%Strong Buy87.45%90.49%N/AN/A
SIGA
SIGA TECHNOLOGIES INC
$608.54M$8.56N/AN/AN/AN/A36.23%-24.21%N/AN/A
ZTS
ZOETIS INC
$77.48B$169.21$226.2033.68%Strong Buy56.80%12.79%N/AN/A
COLL
COLLEGIUM PHARMACEUTICAL INC
$1.24B$38.82$38.60-0.57%Strong Buy5-0.27%N/AN/AN/A
SCYX
SCYNEXIS INC
$55.50M$1.47N/AN/AN/AN/A-15.26%N/AN/AN/A
TXMD
THERAPEUTICSMD INC
$24.22M$2.29N/AN/AN/AN/A387.60%-59.40%N/AN/A
ANIP
ANI PHARMACEUTICALS INC
$1.46B$69.13$80.0015.72%Strong Buy38.00%91.82%N/AN/A
PAHC
PHIBRO ANIMAL HEALTH CORP
$523.71M$12.93$16.0023.74%Hold12.61%107.95%N/AN/A
ALKS
ALKERMES PLC
$4.52B$27.07$33.0021.91%Buy6-2.05%-1.10%N/AN/A
SUPN
SUPERNUS PHARMACEUTICALS INC
$1.87B$34.11$41.0020.20%Strong Buy14.06%460.94%N/AN/A
TLRY
TILRAY BRANDS INC
$1.83B$2.47N/AN/AN/AN/A11.62%N/AN/AN/A
RDY
DR REDDYS LABORATORIES LTD
$12.21B$73.35$80.009.07%Strong Buy18.27%N/AN/AN/A
CRON
CRONOS GROUP INC
$995.19M$2.61$2.00-23.37%Sell122.74%N/AN/AN/A
VTRS
VIATRIS INC
$14.18B$11.94$11.00-7.87%Sell20.28%306.56%N/AN/A
HLN
HALEON PLC
$39.20B$8.49$9.5011.90%Strong Buy23.40%26.14%N/AN/A
EOLS
EVOLUS INC
$811.21M$14.00$22.6061.43%Strong Buy530.56%N/AN/AN/A
ITCI
INTRA-CELLULAR THERAPIES INC
$6.70B$69.20$83.8921.23%Strong Buy936.68%N/AN/AN/A
ZOM
ZOMEDICA CORP
$143.07M$0.15N/AN/AN/AN/AN/AN/AN/AN/A
DCPH
DECIPHERA PHARMACEUTICALS INC
$1.27B$15.73$23.0046.22%Strong Buy432.27%N/AN/AN/A
FTLF
FITLIFE BRANDS INC
$109.28M$23.81N/AN/AN/AN/AN/AN/AN/AN/A
PROC
PROCAPS GROUP SA
$327.19M$2.90N/AN/AN/AN/AN/AN/AN/AN/A
ETON
ETON PHARMACEUTICALS INC
$96.33M$3.75$10.00166.67%Buy1N/AN/A21.58%10.52%
SBFM
SUNSHINE BIOPHARMA INC
$5.97M$0.06N/AN/AN/AN/AN/AN/AN/AN/A
SCTL
SOCIETAL CDMO INC
$114.15M$1.08$1.101.85%Hold112.70%N/AN/AN/A
EGRX
EAGLE PHARMACEUTICALS INC
$68.05M$5.24N/AN/AN/AN/A-12.72%N/AN/AN/A
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
$1.59B$42.34$43.001.56%Hold1N/AN/AN/AN/A
CLVR
CLEVER LEAVES HOLDINGS INC
$8.50M$4.87N/AN/AN/AN/AN/AN/AN/AN/A
AQST
AQUESTIVE THERAPEUTICS INC
$312.26M$4.26$8.60101.88%Buy520.74%N/AN/AN/A
DVAX
DYNAVAX TECHNOLOGIES CORP
$1.62B$12.41$25.00101.45%Buy318.61%N/AN/AN/A
OPTN
OPTINOSE INC
$164.47M$1.46$4.50208.22%Strong Buy229.94%N/AN/AN/A
TLPH
TALPHERA INC
$17.48M$1.03$5.13397.57%Strong Buy2120.80%N/AN/AN/A
TKNO
ALPHA TEKNOVA INC
$108.18M$2.65N/AN/AN/AN/A26.98%N/AN/AN/A
PRGO
PERRIGO CO PLC
$4.36B$32.19$39.0021.16%Strong Buy23.16%N/AN/AN/A
GHSI
GUARDION HEALTH SCIENCES INC
$11.51M$9.03N/AN/AN/AN/AN/AN/AN/AN/A
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
$24.67M$0.69N/AN/AN/AN/AN/AN/AN/AN/A
ACB
AURORA CANNABIS INC
$208.92M$4.39N/AN/AN/AN/A3.96%N/AN/AN/A
RDHL
REDHILL BIOPHARMA LTD
$2.03M$0.53N/AN/AN/AN/AN/AN/AN/AN/A
ORGO
ORGANOGENESIS HOLDINGS INC
$374.78M$2.84$4.8370.18%Strong Buy35.42%N/AN/AN/A
SXTC
CHINA SXT PHARMACEUTICALS INC
$768.37k$1.68N/AN/AN/AN/AN/AN/AN/AN/A
RMTI
ROCKWELL MEDICAL INC
$48.70M$1.66$7.00321.69%Strong Buy25.34%N/AN/AN/A
YCBD
CBDMD INC
$2.83M$0.93$3.00222.58%Strong Buy1N/AN/AN/AN/A
AYTU
AYTU BIOPHARMA INC
$16.93M$3.04N/AN/AN/AN/AN/AN/AN/AN/A
ESPR
ESPERION THERAPEUTICS INC
$495.94M$2.68$12.00347.76%Buy299.65%N/AN/AN/A
BFRI
BIOFRONTERA INC
$7.84M$1.54N/AN/AN/AN/A24.22%N/AN/AN/A
UPC
UNIVERSE PHARMACEUTICALS INC
$7.98M$2.19N/AN/AN/AN/AN/AN/AN/AN/A
EVOK
EVOKE PHARMA INC
$5.17M$0.61N/AN/AN/AN/AN/AN/AN/AN/A
PRFX
PAINREFORM LTD
$3.15M$1.82N/AN/AN/AN/AN/AN/AN/AN/A
ASRT
ASSERTIO HOLDINGS INC
$91.10M$0.96$3.50264.96%Strong Buy2-22.27%N/AN/AN/A
ACOR
ACORDA THERAPEUTICS INC
$16.41M$13.21N/AN/AN/AN/AN/AN/AN/AN/A
PTPI
PETROS PHARMACEUTICALS INC
$3.26M$1.48$4.00170.27%Strong Buy1N/AN/AN/AN/A
HROW
HARROW INC
$467.85M$13.23$26.0096.52%Strong Buy132.19%N/AN/AN/A
CPHI
CHINA PHARMA HOLDINGS INC
$2.45M$0.37N/AN/AN/AN/AN/AN/AN/AN/A
AVDL
AVADEL PHARMACEUTICALS PLC
$1.53B$16.89$23.6740.12%Strong Buy6140.30%N/AN/AN/A
DRRX
DURECT CORP
$37.55M$1.21N/AN/AN/AN/A41.08%N/AN/AN/A
CRDL
CARDIOL THERAPEUTICS INC
$117.28M$1.81N/AN/AN/AN/AN/AN/AN/AN/A
KALA
KALA BIO INC
$21.46M$7.97$22.00176.04%Buy1N/AN/AN/AN/A
INCR
INTERCURE LTD
$123.50M$2.71N/AN/AN/AN/AN/AN/AN/AN/A
COSM
COSMOS HEALTH INC
$9.52M$0.71N/AN/AN/AN/AN/AN/AN/AN/A
CGC
CANOPY GROWTH CORP
$786.32M$8.63N/AN/AN/AN/A-1.96%N/A11.21%4.49%
TAK
TAKEDA PHARMACEUTICAL CO LTD
$43.58B$13.89N/AN/AN/AN/A-1.35%N/AN/AN/A
INDV
INDIVIOR PLC
$2.92B$21.42N/AN/AN/AN/AN/AN/AN/AN/A
DERM
JOURNEY MEDICAL CORP
$68.11M$3.68$8.50130.98%Strong Buy1-0.74%N/AN/AN/A
AKAN
AKANDA CORP
$471.43k$0.12N/AN/AN/AN/AN/AN/AN/AN/A
FLGC
FLORA GROWTH CORP
$20.75M$2.31N/AN/AN/AN/AN/AN/A-897.92%-243.39%
PETQ
PETIQ INC
$538.00M$18.28$29.0058.64%Strong Buy25.48%N/AN/AN/A
OGI
ORGANIGRAM HOLDINGS INC
$174.50M$2.15N/AN/AN/AN/AN/AN/AN/AN/A
EBS
EMERGENT BIOSOLUTIONS INC
$132.07M$2.53$5.0097.63%Strong Buy14.33%N/AN/AN/A
LFCR
LIFECORE BIOMEDICAL INC
$162.20M$5.31N/AN/AN/AN/A22.96%N/AN/AN/A
CPIX
CUMBERLAND PHARMACEUTICALS INC
$23.82M$1.68N/AN/AN/AN/AN/AN/AN/AN/A
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
$58.56M$4.50N/AN/AN/AN/AN/AN/AN/AN/A
IRWD
IRONWOOD PHARMACEUTICALS INC
$1.36B$8.71$18.67114.32%Strong Buy36.50%N/AN/AN/A
SNOA
SONOMA PHARMACEUTICALS INC
$2.59M$0.17N/AN/AN/AN/AN/AN/AN/AN/A
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
$15.82B$14.11$14.432.26%Strong Buy71.48%N/AN/AN/A
AMRX
AMNEAL PHARMACEUTICALS INC
$1.86B$6.06$7.3120.68%Strong Buy45.70%N/AN/AN/A
ALVO
ALVOTECH
$3.26B$12.22$15.0022.75%Buy2112.82%N/AN/AN/A
SHPH
SHUTTLE PHARMACEUTICALS HOLDINGS INC
$6.82M$0.41N/AN/AN/AN/AN/AN/AN/AN/A
HUGE
FSD PHARMA INC
$28.18M$0.72N/AN/AN/AN/AN/AN/AN/AN/A
CYTH
CYCLO THERAPEUTICS INC
$39.91M$1.39N/AN/AN/AN/AN/AN/AN/AN/A
IXHL
INCANNEX HEALTHCARE INC
$56.98M$3.59N/AN/AN/AN/AN/AN/AN/AN/A
ALIM
ALIMERA SCIENCES INC
$204.18M$3.90$8.00105.13%Strong Buy2N/AN/AN/AN/A
BHC
BAUSCH HEALTH COMPANIES INC
$3.88B$10.61$9.00-15.17%Hold13.80%N/AN/AN/A
EVO
EVOTEC SE
$2.77B$7.83N/AN/AN/AN/AN/AN/AN/AN/A
ELAN
ELANCO ANIMAL HEALTH INC
$8.03B$16.28$17.507.49%Buy63.75%N/AN/AN/A
CTLT
CATALENT INC
$10.20B$56.45$55.42-1.83%Hold66.97%N/AN/AN/A
PBH
PRESTIGE CONSUMER HEALTHCARE INC
$3.60B$72.56N/AN/AN/AN/A1.18%N/AN/AN/A
LSDI
LUCY SCIENTIFIC DISCOVERY INC
$2.46M$1.39N/AN/AN/AN/AN/AN/AN/AN/A
BGXX
BRIGHT GREEN CORP
$44.87M$0.24N/AN/AN/AN/AN/AN/AN/AN/A

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Mar 2024?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Neurocrine Biosciences (NASDAQ:NBIX)


Neurocrine Biosciences (NASDAQ:NBIX) is the top pharmaceutical stock with a Zen Score of 67, which is 41 points higher than the pharmaceutical industry average of 26. It passed 22 out of 33 due diligence checks and has strong fundamentals. Neurocrine Biosciences has seen its stock return 43.06% over the past year, overperforming other pharmaceutical stocks by 42 percentage points.

Neurocrine Biosciences has an average 1 year price target of $141.80, an upside of 2.81% from Neurocrine Biosciences's current stock price of $137.92.

Neurocrine Biosciences stock has a consensus Buy recommendation according to Wall Street analysts. Of the 15 analysts covering Neurocrine Biosciences, 40% have issued a Strong Buy rating, 20% have issued a Buy, 40% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the second best pharmaceutical stock with a Zen Score of 61, which is 35 points higher than the pharmaceutical industry average of 26. It passed 19 out of 33 due diligence checks and has strong fundamentals. Kamada has seen its stock return 23.57% over the past year, overperforming other pharmaceutical stocks by 22 percentage points.

Kamada has an average 1 year price target of $11.00, an upside of 96.08% from Kamada's current stock price of $5.61.

Kamada stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Kamada, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Lantheus Holdings (NASDAQ:LNTH)


Lantheus Holdings (NASDAQ:LNTH) is the third best pharmaceutical stock with a Zen Score of 57, which is 31 points higher than the pharmaceutical industry average of 26. It passed 19 out of 33 due diligence checks and has strong fundamentals. Lantheus Holdings has seen its stock lose -22.35% over the past year, underperforming other pharmaceutical stocks by -24 percentage points.

Lantheus Holdings has an average 1 year price target of $100.33, an upside of 61.2% from Lantheus Holdings's current stock price of $62.24.

Lantheus Holdings stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Lantheus Holdings, 66.67% have issued a Strong Buy rating, 33.33% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 8 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Siga Technologies (NASDAQ:SIGA)


Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 12.27%, which is 9 percentage points higher than the pharmaceutical industry average of 3.52%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

2. Alkermes (NASDAQ:ALKS)


Alkermes (NASDAQ:ALKS) has an annual dividend yield of 3.95%, which is the same as the pharmaceutical industry average of 3.52%.

Alkermes's dividend payout ratio of 50% indicates that its dividend yield is sustainable for the long-term.

3. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.71%, which is the same as the pharmaceutical industry average of 3.52%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 129.7% indicates that its dividend yield might not be sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 0.41% in the last day, and up 0.95% over the last week.

We couldn't find a catalyst for why pharmaceutical stocks are up.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Pacira Biosciences (NASDAQ:PCRX)


Pacira Biosciences (NASDAQ:PCRX) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 86, which is 68 points higher than the pharmaceutical industry average of 18. It passed 6 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -26.79% in the past year. It has underperformed other stocks in the pharmaceutical industry by -28 percentage points.

2. Kamada (NASDAQ:KMDA)


Kamada (NASDAQ:KMDA) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Kamada has a valuation score of 86, which is 68 points higher than the pharmaceutical industry average of 18. It passed 6 out of 7 valuation due diligence checks.

Kamada's stock has gained 23.57% in the past year. It has overperformed other stocks in the pharmaceutical industry by 22 percentage points.

3. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Phibro Animal Health has a valuation score of 71, which is 53 points higher than the pharmaceutical industry average of 18. It passed 5 out of 7 valuation due diligence checks.

Phibro Animal Health's stock has dropped -11.92% in the past year. It has underperformed other stocks in the pharmaceutical industry by -13 percentage points.

Are pharmaceutical stocks a good buy now?

59.57% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 29.55% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 54.21x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.